SolarEdge Technologies Earnings Call Transcripts
Fiscal Year 2025
-
Delivered 70% year-over-year Q4 revenue growth and expanded gross margins, achieving positive free cash flow and market share gains in key regions. Guidance for Q1 2026 anticipates continued growth and margin expansion, with strategic investments in product innovation and AI data center solutions.
-
Q3 2025 saw 44% YoY revenue growth, margin expansion, and positive free cash flow, with strong U.S. and European performance. Guidance for Q4 remains robust, and new product launches and a strategic Infineon partnership position the company for future growth.
-
Q2 saw strong revenue and margin growth, with improved cash flow and inventory reduction. Guidance for Q3 projects continued gains, aided by regulatory clarity and new product launches, while U.S. and C&I segments drive growth and Europe shows early recovery.
-
Q1 2025 saw revenue and margin growth, reduced expenses, and positive free cash flow, despite tariff and market headwinds. Guidance for Q2 anticipates higher revenue and continued margin pressure from tariffs, with mitigation efforts underway.
Fiscal Year 2024
-
Q4 2024 saw revenues of $196.2M and a GAAP net loss of $287.4M, but positive free cash flow of $26M was achieved. Inventory write-downs and cost reductions were key, with further improvements and new product launches expected in 2025.
-
Q3 2024 saw a $1.2B net loss driven by a $1.03B impairment, with revenues at $261M and significant inventory write-downs. Aggressive price cuts and promotions aim to clear inventory and regain market share, while positive cash flow is targeted by H1 2025.
-
Distributed solar and batteries are vital for grid flexibility, with VPPs and advanced management software gaining traction. Regulatory uncertainty in key markets like California and the Netherlands impacts demand, while tax credits and regional electricity prices shape solar adoption.
-
Q2 revenue reached $265M with strong U.S. residential and battery sell-through, but margins remain pressured by inventory imbalances and product mix. Inventory normalization is expected by early 2025, with a return to profitability and 23% gross margin targeted at $550M quarterly revenue in Q2 2025.